2021
DOI: 10.1089/mdr.2019.0502
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiological Analysis of Antimicrobial Resistance in Staphylococcus epidermidis in Scotland, 2014–2018

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…According to the study of Høiby et al ( 1997 ), extensive use of quinolone antibiotics and continuous excretion from sweat into the skin can increase the resistance of Staphylococcus epidermidis to quinolone antibiotics, and the increased resistance rates to levofloxacin and ciprofloxacin in this study may be related to this mechanism. Previous studies have shown that rifampicin-resistant Staphylococcus epidermidis strains are more likely to develop resistance to a variety of other antibiotics, and certain rpoB mutant strains have been shown to have heterogeneous resistance to vancomycin (Zalewska et al, 2021 ). In this study, no significant change was showed in the resistance rate of Staphylococcus epidermidis to rifampicin in the past 8 years.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…According to the study of Høiby et al ( 1997 ), extensive use of quinolone antibiotics and continuous excretion from sweat into the skin can increase the resistance of Staphylococcus epidermidis to quinolone antibiotics, and the increased resistance rates to levofloxacin and ciprofloxacin in this study may be related to this mechanism. Previous studies have shown that rifampicin-resistant Staphylococcus epidermidis strains are more likely to develop resistance to a variety of other antibiotics, and certain rpoB mutant strains have been shown to have heterogeneous resistance to vancomycin (Zalewska et al, 2021 ). In this study, no significant change was showed in the resistance rate of Staphylococcus epidermidis to rifampicin in the past 8 years.…”
Section: Discussionmentioning
confidence: 99%
“…In this study, no significant change was showed in the resistance rate of Staphylococcus epidermidis to rifampicin in the past 8 years. However, it should be noticed that the resistance rate to rifampicin reached 10.2% in 2021, higher than the national level (8.7%) and the level of some regions in Europe (8.9%) (Zalewska et al, 2021 ; Hu Fupin et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%